COCH Envoy Medical Inc

Price (delayed)

$0.7006

Market cap

$53.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.01

Enterprise value

$29.5M

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 15
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 2

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory ...

Highlights
Envoy Medical's quick ratio has soared by 192% YoY
Envoy Medical's equity has soared by 184% from the previous quarter and by 142% YoY
Envoy Medical's net income has decreased by 18% YoY but it has increased by 2.7% from the previous quarter
The revenue has grown by 10% YoY but it has contracted by 2.9% from the previous quarter
The gross profit has declined by 21% year-on-year and by 15% since the previous quarter
Envoy Medical's gross margin has decreased by 18% from the previous quarter and by 9% YoY

Key stats

What are the main financial stats of COCH

COCH stock price

How has the Envoy Medical stock price performed over time
Intraday
1.76%
1 week
-0.34%
1 month
0.83%
1 year
-51.35%
YTD
5.97%
QTD
5.34%

Financial performance

How have Envoy Medical's revenue and profit performed over time
Revenue
$234,000
Gross profit
-$727,000
Operating income
-$23.12M
Net income
-$23.11M
Gross margin
-310.7%
Net margin
-9,875.6%
The gross profit has declined by 21% year-on-year and by 15% since the previous quarter
COCH's operating income is down by 19% YoY and by 3.8% QoQ
Envoy Medical's net income has decreased by 18% YoY but it has increased by 2.7% from the previous quarter
Envoy Medical's gross margin has decreased by 18% from the previous quarter and by 9% YoY

Price vs fundamentals

How does COCH's price correlate with its fundamentals

Growth

What is Envoy Medical's growth rate over time

Valuation

What is Envoy Medical stock price valuation
P/E
N/A
P/B
5.3
P/S
206.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
126.07
The EPS has grown by 26% YoY and by 18% from the previous quarter
Envoy Medical's equity has soared by 184% from the previous quarter and by 142% YoY
The P/S is 72% lower than the 5-year quarterly average of 725.6 but 70% higher than the last 4 quarters average of 119.5
The revenue has grown by 10% YoY but it has contracted by 2.9% from the previous quarter

Efficiency

How efficient is Envoy Medical business performance
The ROA has grown by 36% from the previous quarter and by 29% YoY
The ROS has contracted by 9% YoY and by 2.3% from the previous quarter

Dividends

What is COCH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COCH.

Financial health

How did Envoy Medical financials performed over time
The company's total assets is 55% higher than its total liabilities
Envoy Medical's quick ratio has soared by 192% YoY
The company's total assets has surged by 187% YoY
The debt is 91% smaller than the equity
Envoy Medical's equity has soared by 184% from the previous quarter and by 142% YoY
The company's debt to equity has surged by 109% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.